secwatch.observer — SEC 8-K summary
======================================

Issuer:     Semnur Pharmaceuticals, Inc. (SMNR)
CIK:        0001913577
Form:       8-K
Filed at:   2025-06-12T23:59:59+00:00
Accession:  0001213900-25-053576
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Denali Capital Acquisition Corp. extends business combination deadline to July 11, 2025
--------------------------------------------------------------------------------

- Deposited $874.78 into trust account to extend deadline from June 11 to July 11, 2025.
- Extension funded via convertible promissory note from Scilex Holding (SCLX) with principal up to $180,000.
- Note bears no interest, convertible at $10.00/share upon business combination; remaining $56,920.74 available for future extensions.
- Note repayable on earlier of business combination or liquidation of the company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1913577/000121390025053576/0001213900-25-053576-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1913577/000121390025053576/ea0245317-8k_denali.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-053576

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer